Oxbridge Re (OXBR) to Release Quarterly Earnings on Thursday

Oxbridge Re (NASDAQ:OXBR) will likely be posting its Q2 2026 results after the market closes on Thursday, August 13th. Analysts expect Oxbridge Re to post earnings of $0.04 per share and revenue of $1.10 million for the quarter. Parties can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.

Oxbridge Re Trading Down 0.8%

OXBR stock opened at $1.30 on Wednesday. The business has a fifty day moving average price of $1.25 and a 200 day moving average price of $1.07. The company has a debt-to-equity ratio of 0.16, a current ratio of 8.15 and a quick ratio of 8.15. Oxbridge Re has a fifty-two week low of $0.66 and a fifty-two week high of $2.86. The stock has a market capitalization of $10.53 million, a price-to-earnings ratio of -5.20 and a beta of 1.94.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Oxbridge Re stock. Virtu Financial LLC bought a new position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 17,789 shares of the insurance provider’s stock, valued at approximately $32,000. Virtu Financial LLC owned about 0.23% of Oxbridge Re as of its most recent SEC filing. 5.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently commented on OXBR. Maxim Group decreased their target price on Oxbridge Re from $5.00 to $3.00 and set a “buy” rating on the stock in a report on Tuesday, June 16th. Zacks Research upgraded shares of Oxbridge Re to a “hold” rating in a research report on Wednesday, June 17th. Finally, Weiss Ratings raised shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 28th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $3.00.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.